Amneal Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AMRX Nasdaq 2830 www.amneal.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amneal Pharmaceuticals, Inc.

Amneal (AMRX) Stock Looks About Fair Value On Current Earnings - Jul 31st, 2026 11:08 pm
AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance - Jul 31st, 2026 10:03 pm
AMRX Down Despite Q2 Earnings Beat, 2026 Revenue Outlook Raised - Jul 31st, 2026 9:14 am
Amneal Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Jul 30th, 2026 8:50 pm
Amneal Pharmaceuticals Inc (AMRX) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ... - Jul 30th, 2026 3:02 pm
Amneal Pharmaceuticals Q2 Earnings Call Highlights - Jul 30th, 2026 8:04 am
Compared to Estimates, Amneal (AMRX) Q2 Earnings: A Look at Key Metrics - Jul 30th, 2026 7:30 am
Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Surpass Estimates - Jul 30th, 2026 5:20 am
Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9% - Jul 30th, 2026 4:21 am
Amneal (AMRX) Reports Q2: Everything You Need To Know Ahead Of Earnings - Jul 29th, 2026 9:57 am
Spotting Winners: Amneal (NASDAQ:AMRX) And Generic Pharmaceuticals Stocks In Q1 - Jul 29th, 2026 1:41 am
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations - Jul 17th, 2026 6:00 am
3 Reasons AMRX is Risky and 1 Stock to Buy Instead - Jul 15th, 2026 8:13 am
Amneal to Report Second Quarter 2026 Results on July 30, 2026 - Jul 9th, 2026 2:05 pm
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers - Jul 7th, 2026 11:21 am
1 Mooning Stock Worth Your Attention and 2 We Question - Jun 29th, 2026 3:05 am
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations - Jun 29th, 2026 1:00 am
Korro Bio, Inc. (KRRO) Soars 17.6%: Is Further Upside Left in the Stock? - Jun 19th, 2026 6:06 am
FDA Seeks Updated Labeling for Testosterone Therapies - Jun 18th, 2026 3:56 pm
1 Small-Cap Stock for Long-Term Investors and 2 We Find Risky - Jun 17th, 2026 5:16 am